Schaper Benz & Wise Investment Counsel’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Hold
1,185
0.03% 137
2026
Q1
$417K Buy
1,185
+80
+7% +$28.5K 0.03% 133
2025
Q4
$362K Sell
1,105
-174
-14% -$55.2K 0.03% 136
2025
Q3
$361K Sell
1,279
-400
-24% -$116K 0.03% 130
2025
Q2
$469K Sell
1,679
-197
-11% -$55.8K 0.04% 121
2025
Q1
$585K Buy
1,876
+7
+0.4% +$2.07K 0.05% 109
2024
Q4
$487K Hold
1,869
0.04% 118
2024
Q3
$602K Buy
1,869
+790
+73% +$258K 0.05% 109
2024
Q2
$337K Sell
1,079
-117
-10% -$34.4K 0.03% 124
2024
Q1
$340K Buy
1,196
+1
+0.1% +$293 0.03% 124
2023
Q4
$344K Hold
1,195
0.03% 112
2023
Q3
$321K Hold
1,195
0.03% 117
2023
Q2
$265K Hold
1,195
0.03% 123
2023
Q1
$289K Buy
1,195
+57
+5% +$14K 0.03% 121
2022
Q4
$299K Buy
+1,138
New +$305K 0.03% 116
2021
Q3
Sell
-878
Closed -$214K 126
2021
Q2
$214K Hold
878
0.02% 125
2021
Q1
$218K Hold
878
0.02% 118
2020
Q4
$202K Buy
+878
New +$202K 0.02% 122

Other funds holding AMGN

Schaper Benz & Wise Investment Counsel's AMGN Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel held its Amgen (AMGN) position steady in Q2 2026 at 1,185 shares worth $429K. The position accounts for 0.03% of the portfolio, ranked #137.

Schaper Benz & Wise Investment Counsel first reported a position in AMGN in Q4 2020 and has held it in 18 quarters since. The position peaked at $602K in Q3 2024. 1,208 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel held 1,185 shares of Amgen worth $429K as of Q2 2026.
  • Schaper Benz & Wise Investment Counsel left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #137 holding.
  • Schaper Benz & Wise Investment Counsel first reported a position in Amgen in Q4 2020 and has held it in 18 quarters since.
  • Schaper Benz & Wise Investment Counsel's Amgen position peaked at $602K in Q3 2024.
  • 1,208 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.